Ensign Peak Advisors
CDLX icon

Ensign Peak Advisors’s Cardlytics CDLX Stock Holding History

Ensign Peak Advisors’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,782
Closed -$162K – 1764
2023
Q1 		$162K Hold
4,782
– – ﹤0.01% 1746
2022
Q4 		$276K Buy
4,782
+3,785
+380% +$234K ﹤0.01% 1716
2022
Q3 		$94K Buy
997
+147
+17% +$20.9K ﹤0.01% 2104
2022
Q2 		$190K Hold
850
– – ﹤0.01% 1807
2022
Q1 		$467K Hold
850
– – ﹤0.01% 1578
2021
Q4 		$562K Buy
+850
New +$650K ﹤0.01% 1588

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ensign Peak Advisors's CDLX Position: Q2 2023 in Review

Ensign Peak Advisors sold out of Cardlytics (CDLX) in Q2 2023, closing a stake of 4,782 shares — an estimated $162K sold.

Ensign Peak Advisors first reported a position in CDLX in Q4 2021 and held it in 6 quarters. The position peaked at $562K in Q4 2021. 110 funds tracked by Wall St. Rank hold CDLX as of Q2 2023.

  • Ensign Peak Advisors reported no remaining Cardlytics position as of Q2 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 4,782 Cardlytics shares in Q2 2023, an estimated $162K.
  • Ensign Peak Advisors first reported a position in Cardlytics in Q4 2021 and held it in 6 quarters.
  • Ensign Peak Advisors's Cardlytics position peaked at $562K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Cardlytics as of Q2 2023.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.